Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
The Lancet. Rheumatology|May 26, 2025
Towards precision medicine in antiphospholipid syndromeChary Lopez-Pedrera, Carlos Pérez-Sánchez, Maria G TektonidouCritical Reviews in Oncology/Hematology|November 2, 2010
VEGF targeted therapy in acute myeloid leukemiaAntonio Rodriguez-Ariza, Chary Lopez-Pedrera, Enrique Aranda, et al.Medicina Clinica|June 17, 2017
Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approachesChary Lopez-Pedrera, M Ángeles Aguirre-Zamorano, Carlos Pérez-SánchezBest Practice & Research. Clinical Rheumatology|October 9, 2012
Catastrophic antiphospholipid syndrome (CAPS)Savino Sciascia, Chary Lopez-Pedrera, Dario Roccatello, et al.Current Drug Targets|January 19, 2012
To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancerChary Lopez-Pedrera, Patricia Ruiz-Limon, Araceli Valverde-Estepa, et al.Rheumatology (Oxford, England)|February 5, 2016
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndromeSavino Sciascia, Chary Lopez-Pedrera, Irene Cecchi, et al.Current Rheumatology Reports|November 23, 2011
Potential use of statins in the treatment of antiphospholipid syndromeChary Lopez-Pedrera, Patricia Ruiz-Limon, M Angeles Aguirre, et al.Frontiers in Immunology|May 2, 2019
New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics ApproachesChary Lopez-Pedrera, Nuria Barbarroja, Alejandra Mª Patiño-Trives, et al.Leukemia & Lymphoma|June 20, 2007
Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemiaNuria Barbarroja, Luis Arístides-Torres, Vanessa Hernandez, et al.Autoimmunity Reviews|September 16, 2018
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targetsIrene Cecchi, Ivan Arias de la Rosa, Elisa Menegatti, et al.Pageof 4